The beverages we drink represent a substantial source of our daily calories and nutrients, yet standardized methods for tracking beverage consumption have been limited. In the latest and most comprehensive assessment of worldwide ...
Jun 8, 2019
1
47
Female genital mutilation (FGM) is a leading cause of death in the countries where it is practiced, with over 44,000 additional women and young girls dying each year, a new study reveals.
Aug 17, 2023
1
59
Scientists at the University of Glasgow and partner institutes have developed an inexpensive, fast and simple way to identify the aging mosquitos which transmit the deadly malaria parasite.
Mar 21, 2022
0
26
(Medical Xpress)—Gérard Niyondiko along with colleagues Frank Langevin and Lisa Barutel has posted a project on the crowd source funding site ulule for a product called Faso Soap. They claim the soap can cut in half the ...
Access to mobile technology is extremely common in the United States, so much so that it is hard to imagine daily life without it. More than 86% of Americans report using their smartphone as their primary source of obtaining ...
Apr 5, 2023
0
21
Releasing genetically modified mosquitoes into the wild could provide a promising strategy for tackling malaria in sub-Saharan Africa, according to new research.
Feb 10, 2022
0
22
An Ebola vaccine developed by Canadian researchers and considered by the WHO to be the first effective treatment against the virus will soon start a new phase of clinical trials, Ottawa announced Tuesday.
Oct 18, 2016
0
0
An experimental malaria vaccine tested on children in Burkina Faso has shown "a high level of efficacy" in protecting against the disease, a study published in the United States said Wednesday.
Sep 14, 2011
0
0
The plasmodium parasite, which transmits malaria to humans through infected mosquitos, triggers changes in human genes that alter the body's adaptive immune response to malarial infections, according to a team of researchers ...
Oct 9, 2020
0
63
Phase III trial results of the R21/Matrix-M vaccine developed by Oxford University and Serum Institute of India Pvt Ltd, leveraging Novavax's Matrix-M adjuvant, has confirmed high efficacy and supported regulatory approvals ...
Feb 2, 2024
0
32
